Pancreatic Cancer Research

ResearcherVan Andel InstituteActive in the last 2 years

Ying Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6540-0473; OpenAlex author ID A5100414285. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
40
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 3 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 9

  1. Spatially Controlled Co-Delivery of Diagnostic and Therapeutic Agents Using DNA Nanoframeworks for Pancreatic Cancer Precision Therapy. Co-author DOI 10.1002/anie.202500566↗
  2. A Self-Assembled 3D Model Demonstrates How Stiffness Educates Tumor Cell Phenotypes and Therapy Resistance in Pancreatic Cancer. Co-author DOI 10.1002/adhm.202301941↗
  3. Comment on "Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression". First author DOI 10.4251/wjgo.v15.i2.368↗
  4. Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology. Co-author DOI 10.1038/s41467-021-25921-9↗
  5. Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. Co-author DOI 10.1158/1078-0432.ccr-20-2475↗
  6. Formulation Comprising Arsenic Trioxide and Dimercaprol Enhances Radiosensitivity of Pancreatic Cancer Xenografts. Co-author DOI 10.1177/15330338211036324↗
  7. Sequential therapy for pancreatic cancer by losartan- and gemcitabine-loaded magnetic mesoporous spheres. Co-author DOI 10.1039/c9ra02180a↗
  8. The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. First author DOI 10.1038/s41598-017-04164-z↗
  9. Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer. Co-author DOI 10.1186/s13045-016-0237-6↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shi Liu · 1 shared paper, 2023 · strength 0.31
  2. Jian Yang · 1 shared paper, 2023 · strength 0.31
  3. Daniela Loessner · 2 shared papers, 2021–2024 · strength 0.30
  4. Sara Maria David Trabulo · 2 shared papers, 2021–2024 · strength 0.30
  5. David Osuna de la Peña · 2 shared papers, 2021–2024 · strength 0.30
  6. Rita Teresa Lawlor · 2 shared papers, 2021–2024 · strength 0.30
  7. Christopher Heeschen · 2 shared papers, 2021–2024 · strength 0.30
  8. Aldo Scarpa · 2 shared papers, 2021–2024 · strength 0.30
  9. Chi Yao · 1 shared paper, 2025 · strength 0.26
  10. Dayong Yang · 1 shared paper, 2025 · strength 0.26
  11. Nachuan Song · 1 shared paper, 2025 · strength 0.26
  12. Oliver M.T. Pearce · 1 shared paper, 2024 · strength 0.18
  13. Renyan Tang · 1 shared paper, 2021 · strength 0.17
  14. Jinbin Han · 1 shared paper, 2021 · strength 0.17
  15. Daniel Barnett · 2 shared papers, 2017–2021 · strength 0.17
  16. Randall E. Brand · 2 shared papers, 2017–2021 · strength 0.17
  17. Richard R. Drake · 2 shared papers, 2017–2021 · strength 0.17
  18. Brian B. Haab · 2 shared papers, 2017–2021 · strength 0.17
  19. Aatur Dilip Singhi · 2 shared papers, 2017–2021 · strength 0.17
  20. Ying Huang · 2 shared papers, 2017–2021 · strength 0.17
  21. Diana Behrens · 1 shared paper, 2021 · strength 0.12
  22. Mert Erkan · 1 shared paper, 2021 · strength 0.12
  23. Shreya Sharma · 1 shared paper, 2021 · strength 0.12
  24. Peter J. Allen · 1 shared paper, 2021 · strength 0.10
  25. Amer H. Zureikat · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.